Ventyx Biosciences Inc (NASDAQ: VTYX) on Tuesday, soared 6.78% from the previous trading day ,before settling in for the closing price of $4.72. Within the past 52 weeks, VTYX’s price has moved between $1.87 and $40.58.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 19.10%. With a float of $47.09 million, this company’s outstanding shares have now reached $59.24 million.
Let’s look at the performance matrix of the company that is accounted for 80 employees.
Ventyx Biosciences Inc (VTYX) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Ventyx Biosciences Inc is 20.53%, while institutional ownership is 89.16%. The most recent insider transaction that took place on Apr 02 ’24, was worth 23,299. In this transaction CEO AND PRESIDENT of this company sold 4,312 shares at a rate of $5.40, taking the stock ownership to the 1,578,250 shares. Before that another transaction happened on Apr 02 ’24, when Company’s CHIEF BUSINESS OFFICER sold 1,651 for $5.40, making the entire transaction worth $8,921. This insider now owns 284,999 shares in total.
Ventyx Biosciences Inc (VTYX) Latest Financial update
As on 12/30/2023, Multinational firm has announced its last quarter scores, in which it reported -$0.79 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.9) by $0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.64 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 19.10% per share during the next fiscal year.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
Ventyx Biosciences Inc (VTYX) is currently performing well based on its current performance indicators. A quick ratio of 11.87 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.29, a number that is poised to hit -0.68 in the next quarter and is forecasted to reach -2.59 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
Ventyx Biosciences Inc (NASDAQ: VTYX) saw its 5-day average volume 1.22 million, a negative change from its year-to-date volume of 4.13 million. As of the previous 9 days, the stock’s Stochastic %D was 12.67%. Additionally, its Average True Range was 0.67.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 33.02%, which indicates a significant increase from 12.61% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.81% in the past 14 days, which was lower than the 132.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.48, while its 200-day Moving Average is $16.42. Nevertheless, the first resistance level for the watch stands at $5.29 in the near term. At $5.53, the stock is likely to face the second major resistance level. The third major resistance level sits at $5.87. If the price goes on to break the first support level at $4.71, it is likely to go to the next support level at $4.37. The third support level lies at $4.13 if the price breaches the second support level.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
Market capitalization of the company is 298.62 million based on 59,252K outstanding shares. Right now, sales total 0 K and income totals -192,960 K. The company made 0 K in profit during its latest quarter, and -46,750 K in sales during its previous quarter.
